-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

605.P1.74 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster I

Symposia: Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Mackenzie Long, DVM1,2, Shirsha Koirala, BS1*, Shelby Sloan, BS2,3, Fiona Brown, BS1, Sheetal Tallada, BS1*, Claire Hinterschied, BS1*, Kara Corps, DVM, PhD, DACVP2*, JoBeth Helmig-Mason, Msc4*, Ji Hyun Chung, PhD1*, Peggy Scherle, PhD5, Kris Vaddi, PhD5, Cem Meydan, PhD6*, Jonathan Foox, PhD6*, Daniel Butler, PhD6*, Christopher E Mason, PhD6*, Lapo Alinari, MD, PhD3, Bradley W Blaser, MD, PhD1 and Robert A. Baiocchi, MD, PhD3

1Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
2Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH
3Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
4Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH
5Research and Development, Prelude Therapeutics, Wilmington, DE
6Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY

Anna Kuchnio, PhD1, Danlin Yang, PhD2*, Nele Vloemans1*, Cassandra Lowenstein2*, Ivo Cornelissen1*, Ricardo Amorim, PhD1*, Chao Han2*, Siddharth Sukumaran, PhD2*, Lut Janssen1*, Toon Suls1*, Mariette Bekkers1*, Elena Lasorsa, PhD1*, Lorena Fontana, PhD1*, Nicole Medeiros2*, Bingyuan Wu, PhD2*, Jun Chen2*, Michael Feldkamp, PhD2*, Sheng-Jiun Wu2*, Habtom Habte, PhD2*, John Krayer2*, Cam Holland2*, M. Phillip Deyoung, PhD2, Yusri A Elsayed, MD, PhD2* and Ulrike Philippar, PhD1

1Janssen Research & Development, Beerse, Belgium
2Janssen Research & Development, Spring House, PA

Grazia Fazio, PhD1*, Manuel Quadri, PhD student1*, Silvia Bresolin, PhD2*, Chiara Palmi, PhD3*, Michela Bardini, PhD3*, Athanasios Oikonomou1*, Jia-Wey Tu4*, Katerina Scharov4*, Alberto Peloso5*, Titus Watrin6*, Sanil Bhatia, PhD4*, Arndt Borkhardt, MD4, Andrea Biondi, MD1 and Giovanni Cazzaniga, PhD7,8*

1Tettamanti Research Center, Dept. Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
2SDB Department, Pediatric Hemato-Oncology, University of Padova, Padova, Italy
3Tettamanti Research Center, Pediatrics, Department of Medicine, University of Milano-Bicocca, Monza, Italy
4Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
5Pediatric Haematology, Oncology and Stem Cell Transplant Division, Women and Child Health Department, Padua University and Hospital, Padova, Italy
6Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany
7Medical Genetics, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
8Tettamanti Research Center, Pediatrics, University of Milano-Bicocca / Fondazione Tettamanti, Monza, Italy

Olga Kersy1,2*, Mali Salmon-Divon1,3*, Maria Gomes da Silva4*, Ana Filipa Moita, MD4*, Jose Cabecadas5*, Pavel Klener Jr., Prof., MD, PhD6,7*, Marek Trněný, MD, prof8, May Basood, MD9*, Ofer Shpilberg, MD, MPH2,3,9* and Oshrat Hershkovitz-Rokah, Ph.D1,2*

1Department of Molecular Biology, Faculty of Natural Sciences, Ariel University, Ariel, Israel
2Translational Research Lab, Assuta Medical Centers, Tel-Aviv, Israel
3Adelson School of Medicine, Ariel University, Ariel, Israel
4Department of Hematology, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
5Pathology, Instituto Português de Oncologia, Lisbon, Portugal
6Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
7First Department of Medicine, First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic
8First Department of Medicine - Hematology, General University Hospital Prague and First Faculty of Medicine, Charles University, Prague, Czech Republic
9Institute of Hematology, Assuta Medical Centers, Tel-Aviv, Israel

Chenyan Yang1*, Chunhua Song, MD,PhD2,3 and Zheng Ge, MD, PhD1

1Department of Hematology, Zhongda Hospital, School of Medicine, Institute of Hematology, Southeast University, Nanjing, China
2Hershey Medical Center, Pennsylvania State University Medical College, Hershey
3Division of Hematology, The Ohio State University Wexner Medical Center, the James Cancer Hospital, Columbus

Kadriye Nehir Cosgun, PhD1*, Huda Jumaa, PhD2,3*, Mark E. Robinson, PhD1*, Lai N. Chan, PhD1, Jaewoong Lee, PhD1,4*, Kohei Kume, PhD5*, David Fonseca Arce1*, Julia Jellusova, PhD6,7* and Markus Müschen, MD1

1Center of Molecular and Cellular Oncology and Department of Immunobiology, Yale University, New Haven, CT
2Signalling Research Centers BIOSS and CIBSS, Freiburg, Germany
3Department of Molecular Immunology, Institute of Biology III, Albert Ludwigs University of Freiburg, Freiburg, Germany
4School of Biosystems and Biomedical Sciences, College of Health Science, Korea University, Seoul, Korea, Republic of (South)
5Center of Molecular and Cellular Oncology and Department of Immunobiology, Yale University, Duarte, CA
6Institute of Clinical Chemistry and Pathobiochemistry, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
7TranslaTUM, Center for Translational Cancer Research, Technical University Munich, Munich, Germany

Elshafa Hassan Ahmed, DVM, PhD1,2*, Christoph Weigel, PhD3*, Rachel Saadey, BS4*, Eric Brooks, BS4*, Taylor Cash4*, Charlene Mao1*, Aneeq Yasin5*, Alexa Wandke4*, Ethan Baiocchi4*, Anna Mozhenkova, MD, PhD4*, Fiona Brown, BS6, Shelby Sloan, BS7,8*, JoBeth Helmig-Mason, Msc9*, Kaylee Harrison10*, Kris Vaddi, PhD11, Peggy Scherle, PhD11, Neha Bhagwat12*, Wing Keung Chan, PhD7*, Olivier Elemento, PhD13*, Christopher E Mason, PhD13*, Christopher C. Oakes, PhD14, Robert A. Baiocchi, MD, PhD6,15 and Polina Shindiapina, MD, PhD4,7

1Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH
2Dept. of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH
3Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, OH
4Comprehensive Cancer Center, The Ohio State University, Columbus, OH
5The University of Texas Rio Grande Valley, Edinburg, TX
6Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
7Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
8Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH
9Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH
10The Ohio State University, Columbus, OH
11Research and Development, Prelude Therapeutics, Wilmington, DE
12Prelude Therapeutics, Wilmington, DE
13Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY
14The Ohio State University Comprehensive Cancer Center, Columbus, OH
15The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Division of Hematology, Columbus, OH

Claire Hinterschied, BS1*, Fiona Brown, BS2, Janani Ravikrishnan, PhD1, JoBeth Helmig-Mason, Msc1*, Kaylee R. Harrison1*, Aneeq Yasin1*, Shelby Sloan, BS2,3, Mackenzie Long, DVM2,3, Neha Bhagwat, PhD4, Kris Vaddi, PhD4, Peggy Scherle, PhD4, Jennifer A. Woyach, MD1, Selina Chen-Kiang, PhD5, Olivier Elemento, PhD6*, Jihye Paik, PhD7 and Robert A. Baiocchi, MD, PhD2

1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH
2Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
3Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH
4Research and Development, Prelude Therapeutics, Wilmington, DE
5Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
6Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY
7Weill Cornell Medical College, New york, NY

James Boncan, BSc, MSc1*, Jeremy Hamilton, MB, BAO, Bch, FRCP, FRCPath2*, Karen McCloskey, BSc, PhD1* and Ken I Mills, BSc, PhD, FRCPath1

1Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom
2Haematology Department, Belfast City Hospital, Belfast, United Kingdom

Franziska Gsottberger, MSc1*, Christina Meier1*, Anna Ammon1*, Scott Parker2*, Kerstin Wendland1*, Rebekka George1*, Srdjan Petkovic1*, Lisa Mellenthin1*, Charlotte Emmerich1*, Gloria Lutzny-Geier1*, Markus Metzler, MD3*, Andreas Mackensen, MD1*, Vidyalakshmi Chandramohan2* and Fabian Mueller, MD1*

1Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany
2Department of Neurosurgery, Duke University Medical Center, Durham, NC
3Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany

Roman Generalov1*, Elisa Fiorito, PhD1*, Stian Foss, PhD2,3*, Veronique Pascal, PhD, PharmD1*, Helen Heyerdahl, PhD1*, Ada Repetto-Llamazares, PhD1*, Jan Terje Andersen, PhD2,3*, Geir E Tjønnfjord, MD4, Sigrid Strand Skånland, PhD5,6* and Jostein Dahle, PhD1*

1Research and Development department, Nordic Nanovector ASA, Oslo, Norway
2Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway
3Institute of Clinical Medicine and Department of Pharmacology, University of Oslo, Oslo, Norway
4Department of Haematology, Oslo University Hospital, Oslo, Norway
5K.G. Jebsen Centre for B cell malignancies and Institute of Clinical Medicine, University of Oslo, Oslo, Norway;, Oslo, Norway
6Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo, Norway, Oslo, Norway

Fabian Ullrich1,2,3*, Trixie Verhoeven4*, Katarzyna Andryka2,3*, Saskia Schmitz2,3*, Sofia Beatriz Soler2,3*, Thomas Zillinger2*, Gunther Hartmann2* and Eva Bartok2,3,4*

1Department of Hematology and Stem Cell Transplantation, University of Duisburg-Essen, Essen, Germany
2Institute of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany
3Institute of Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany
4Unit of Experimental Immunology, Department of Biomedical Sciences, Institute of Tropical Medicine, University of Antwerp, Antwerp, Belgium

Tim H. Brummendorf, MD1, Patrick Medd, MD PhD2, Raphael Koch, MD3*, Stephan Stilgenbauer, MD4, Shringi Sharma5*, Yun He6*, Stefanie Meyer6*, Margaret C. Wey6*, Jamal Saeh6*, Richard F. Olsson7* and Arnon P. Kater, MD PhD8*

1Uniklinik RWTH Aachen, Aachen, Germany
2University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
3University Medical Center Göttingen, Göttingen, Nds, DEU
4Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany
5Oncology R&D, AstraZeneca, South San Francisco, CA
6Oncology R&D, AstraZeneca, Boston, MA
7Oncology R&D, AstraZeneca, Gothenburg, Sweden
8Cancer Center Amsterdam, Amsterdam, Netherlands

Govinda Poudel, PhD1,2,3*, David T Yeung, MBBS, PhD, BSc, FRACP, FRCPA2,4,5,6, Deborah L White, PhD, FFSc(RCPA)1,2,7,8,9, Timothy Hughes, MD, MBBS, FRACP, FRCPA1,2,6,10 and Ilaria S Pagani, PhD1,2,9*

1School of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia
2Australasian Leukaemia and Lymphoma Group (ALLG), Melbourne, VIC, Australia
3Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, Australia
4Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia
5Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
6Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
7Department of Paediatrics, The University of Adelaide, Adelaide, SA, Australia
8School of Biological Sciences, The University of Adelaide, Adelaide, SA, Australia
9Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia
10South Australian Health and Medical Research Institute SAHMRI, Adelaide, SA, Australia

Anna Montanaro1*, Anna D'Antuono1*, Lucas Moron Dalla Tor1*, Pietro Andrei1*, Alessia Ciringione1*, Elisa Cerretani2*, Federica Vento2*, Luca Pagliaro1*, Andrea Gherli1*, Bruno Lorusso1*, Elisa Simoncini1*, Raffaella Zamponi1*, Costanza Salvatori1*, Giannalisa Todaro, PhD3*, Roberta La Starza4*, Cristina Mecucci, MD, PhD4, Gabriella Sammarelli, PhD3*, Matteo Marchesini, PhD1,5* and Giovanni Roti, M.D., Ph.D.1,6

1Department of Medicine and Surgery, University of Parma, Parma, Italy
2Department of Medical Science, University of Ferrara, Ferrara, Italy
3Hematology and BMT Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
4Department of Medicine, Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
5IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" IRST, Meldola (FC), Italy
6Hematology and BMT Unit, Azienda Ospedaliera-Universitaria di Parma, Parma, Italy

Willem Cox, MSc1*, Miriam Butler, PhD2*, Dorette S van Ingen Schenau2*, Nadia Anderson2*, Lieke de Groot, BSc.2*, Laurens T van der Meer, PhD2 and Frank N van Leeuwen, PhD2

1Princess Máxima Center for Pediatric Oncology, Nijmegen, Netherlands
2Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

Jutta Deckert, PhD1, Jenny Thirlway, PhD1*, Justyna Mysliwy, PhD1*, Adam Lodge, PhD1*, Yun-Hee Park, PhD2*, Hyun-Min Ryu, MS2*, Na Ra Han, MS2*, Ho Young Song, PhD2*, Chul-Woong Chung, PhD2* and Robert J Lutz, PhD1

1Iksuda Therapeutics Ltd, Newcastle-upon-Tyne, United Kingdom
2LegoChem Biosciences, Inc., Daejeon, Korea, Republic of (South)

Andrea Aroldi, MD1*, Mario Mauri, PhD2*, Matteo Villa, MS3*, Federica Malighetti, MS3*, Federica Cocito, MD4*, Claudia Voena, PhD5*, Roberto Chiarle, MD6,7,8, Luca Mologni, PhD9*, Rocco Piazza, MD, PhD10* and Carlo Gambacorti-Passerini, MD11

1Hematology Division. San Gerardo Hospital, School of Medicine and Surgery. University of Milano-Bicocca, Monza, Italy
2Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
3School of Medicine and Surgery. University of Milano-Bicocca. Monza. Italy, Monza, Italy
4Hematology Division, San Gerardo Hospital, Monza, Italy
5University of Torino, Torino, Italy
6Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
7Division of Hematopathology, European Institute of Oncology (IEO) IRCCS, Milan, Italy
8Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA
9Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy, Monza, DC, Italy
10Hematology, Department of Medicine, University of Milano-Bicocca, Monza, Italy
11Dept of Medicine and Surgery, University of Milano Bicocca, Monza, MB, Italy

Jialei Qi1*, Sascha Endres1*, Deyan Yordanov Yosifov, PhD2*, Eugen Tausch, MD2*, Rashmi Priyadharshini Dheenadayalan3*, Xiang Gao4*, Annika Scheffold, PhD5*, Felix Seyfried6*, Lüder Meyer7*, Christof Schneider, MD2*, Daniel Mertens8*, Peter Gierschik, PhD9*, Martin Wist3*, Stephan Stilgenbauer, MD2 and Billy Michael Chelliah Jebaraj, PhD10*

1University of Ulm, Ulm, Germany
2Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
3University of Ulm, Ulm, DEU
4Internal Medicine III, University Ulm, Ulm, AL, DEU
5Department of Internal Medicine III, Ulm University, Ulm, Germany
6Department of Pediatrics and Adolescent, University Hospital Ulm, Ulm, Germany
7Ulm University Medical Center, Ulm, DEU
8Ulm University, Ulm, DEU
9University Ulm, Ulm, Germany
10Department of Internal Medicine III, University of Ulm, Ulm, Baden Wurttemberg, Germany

Johannes Sam, PhD1*, Thomas Hofer, PhD1*, Christine Kuettel1*, Christina Claus, PhD1*, Sylvia Herter, PhD1*, Guy Georges, PhD2*, Jenny Tosca Thom, PhD1*, Leo Kunz, PhD1*, Samuel Gebhardt1*, Florian Limani1*, Stefanie Briner1*, Silvia Jenni1*, Anne Schönle1*, Marine Le Clech1*, Ahmet Varol1*, Esther Bommer1*, Birte Appelt1*, Sara Colombetti, PhD1*, Stephan Gasser, PhD1*, Marina Bacac, PhD1*, Christian Klein, PhD3 and Pablo Umana, PhD1

1Roche Innovation Center Zurich, Schlieren, Switzerland
2Roche Innovation Center Munich, Penzberg, Germany
3Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland

Yanxin Chen, M.D. & Ph.D.*, Jiazheng Li, M.D.*, Yongzhi Zheng, MD*, Zhengjun Wu, Ph.D.*, Yangqi Xu* and Jianda Hu

Department of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China

Carla Portocarrero1*, Laura Gleason1*, Lauren Banner1*, Daniel Joffe1*, Sahithi Talasila1*, Pierluigi Porcu, MD2 and Neda Nikbakht, MD, PhD1*

1Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
2Sidney Kimmel Cancer Center at Jefferson Health, Thomas Jefferson University, Philadelphia, PA

Haihui Lu, PhD1, Adwait Oka1*, Michelle Coulson, PhD2*, Joseph Ryan Polli, PhD1*, Kimberly Aardalen3*, Melissa Ramones1*, Dana B Walker, DVM, PhD4*, Ana Carrion1*, Dylan Alexander, PhD1*, Matthieu Klopfenstein5*, Masaki Akiyama6*, Francesca Rucci, PhD5*, Brian Granda1* and Alessandro Pastore, MD7

1Novartis Institutes for Biomedical Research, Cambridge, MA
2Preclinical Safety, Novartis Pharmaceuticals, Cambridge, MA
3Novartis Institutes For Biomedical Research, Cambridge, MA
4Novartis Institutes for BioMedical Research, Cambridge, MA
5Novartis Institutes for Biomedical Research, Basel, Switzerland
6Translational Clinical Oncology, Novartis Institutes for Biomedical Research, East Hanover, NJ
7Translational Clinical Oncology, Novartis Institutes for BioMedical Research, East Hanover, NJ

Kristyna Kupcova, PhD1,2*, Jana Senavova, MD1,2*, Vaclav Herman, MD3,4*, Tereza Chrbolkova, MSc1*, Iva Ondeckova, MD1,2*, Mariana Pacheco-Blanco, MSc PhD1* and Ondrej Havranek, MD, PhD1,2

1BIOCEV, First Faculty of Medicine, Charles University, Prague, Czech Republic
2First Department of Internal Medicine - Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
31st Department Medicine, 1st Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic
4BIOCEV, 1st Faculty of Medicine, Charles University, Vestec, Czech Republic

Hiroko Nishida, MD, PhD1, Reiko Suzuki, Ph.D.2*, Kiyora Nakajima1*, Mutsumi Hayashi, M.D., Ph.D.1* and Michiie Sakamoto, M.D., Ph.D.1*

1Department of Pathology, Keio University, School of Medicine, Tokyo, Japan
2Collaborative Research Resources, Keio University School of Medicine, Tokyo, Japan

Simone C. Oostindie, PhD1*, Mir Farshid Alemdehy, PhD1*, Maarten L. Janmaat, PhD1*, Jenny M. Meerding1*, Kristel Kemper, PhD1*, Patrick J. Engelberts, PhD1*, Bart E.C.G. De Goeij, PhD1*, David Satijn, PhD1*, A. Kate Sasser, PhD2* and Esther C.W. Breij, PhD1*

1Genmab, Utrecht, Netherlands
2Genmab, Princeton, NJ

*signifies non-member of ASH